Penetrating the Managed Care Markets
In the U.S. in 2003, 3.5 billion prescriptions worth $220 billion were dispensed. Of those prescriptions, 74% were paid by some form of managed care and 13% by Medicaid. Only 13% were private pay.
With the aging of the baby boomer generation and the increasing longevity of the population, the third-party payor market will continue to experience strong growth.
While managed care and Medicaid have become the most important markets for virtually every pharmaceutical manufacturer, gaining access to them is challenging and takes experience. These challenges include
|
|
understanding the managed care culture
|
|
|
|
|
targeting the right accounts
|
|
|
|
|
understanding each account’s unique decision-making processes
|
|
|
|
|
penetrating the organizational structure to gain access to decision makers
|
|
|
|
|
correctly positioning products for acceptance on formulary lists
|
|
|
|
|
developing and negotiating profitable contracts
|
Accelerating Managed Care Access Since 1995
Opening the door to managed care reimbursement is complex and challenging. It demands firsthand knowledge of the culture, decision-making processes, and the key decision makers in the managed care and Medicaid arenas.
For companies without their own account groups or those that require additional support, MC Access is the answer in terms of both expertise and cost-effectiveness. MC Access has the expertise and credibility to open doors for your company.
MC Access is the pharma industry's premier independent managed care contracting group. On behalf of our pharmaceutical clients, MC Access will design, negotiate, implement, and support managed care and Medicaid contracts and programs.
|
